EW vs OGEN · P/E 47, rev $1.39B vs rev $37.7K
Edwards Lifesciences Corp (EW) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the EW and OGEN stock pages for the full models.
Not investment advice.